# US 2019/0184056 A1 · Method for using an adhesive composition in bone preservation and augmentation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0184056 A1
- Document ID: US20190184056A1
- Status: Published application
- Kind: A1
- Application number: 15/844,450
- Filed: 2017-12-15
- Published: 2019-06-20
- Earliest claimed: 2017-12-15
- Inventors: MANAR M. JAMAL
- Web page: https://patentgrep.com/patent/US20190184056A1

## CPC

- A61L 24/0036: {Porous materials, e.g. foams or sponges}
- A61C 19/003: {Apparatus for curing resins by radiation}
- A61F 2/2857: {for cadavers (devices for autopsy A61B16/00)}
- A61L 24/0005: {Ingredients of undetermined constitution or reaction products thereof}
- A61L 24/0015: {Medicaments; Biocides}
- A61L 24/0042: {Materials resorbable by the body}
- A61L 24/0084: {containing fillers of phosphorus-containing inorganic compounds, e.g. apatite}
- A61L 24/02: containing inorganic materials
- A61L 24/102: {Collagen}
- A61L 27/025: {Other specific inorganic materials not covered by A61L27/04 - A61L27/12}
- A61L 27/10: Ceramics or glasses
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/24: Collagen
- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/365: {Bones}
- A61L 27/3821: {Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/3847: {Bones}
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- A61C 8/0006: {Periodontal tissue or bone regeneration (support means for endoprosthetic bone substitute or bone graft implants A61F2/2846)}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/3093: {for promoting ingrowth of bone tissue}
- A61F 2250/0081: Prosthesis for animals
- A61L 2300/414: Growth factors
- A61L 2300/604: Biodegradation
- A61L 2300/64: Animal cells
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/12: for dental implants or prostheses
- A61L 2430/34: for soft tissue reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A method comprising the steps of applying an adhesive composition to a substrate bone repair region. The adhesive composition comprises a porous, biocompatible, biodegradable, resorbable, non-toxic, and polymerizable composition. The substrate bone repair region comprises a bone structure, implant or device surface, or tooth surface. The adhesive composition is cured to provide a polymerized adhesive composition resulting in repairing or augmenting the substrate bone repair region. The adhesive composition may be mixed with a bone graft material before application. The adhesive composition may be additionally applied to a barrier membrane that is placed over the substrate bone repair region where the adhesive composition or combination of adhesive composition and bone graft material is applied.

## Claims

### Claim 1

A method comprising the steps of:
applying an adhesive composition to a substrate bone repair region, said adhesive composition comprises at least a bovine serum albumin or collagen based adhesive;
wherein said bovine serum albumin or collagen based adhesive composition comprises at least a porous, biocompatible, biodegradable, resorbable, or polymerizable adhesive composition;
wherein said substrate bone repair region comprises at least one of a bone structure, an implant device surface, and a tooth surface;
curing said bovine serum albumin or collagen based adhesive composition applied to said substrate bone repair region with a curing device employing at least light curing or chemical curing;
wherein said curing step is configured to generate a polymerized bovine serum albumin or collagen based adhesive composition on said substrate bone repair region; and
wherein said curing step is further configured to be operable for at least one of repairing said bone structure, filling gaps between said bone structure or implant device surface, and filling gaps between said bone structure or tooth surface.

### Claim 2 (depends on 1)

The method of claim 1, wherein said bovine serum albumin or collagen based adhesive composition comprises pores, in which said pores are configured to be operable for allowing free transport of fluids through the adhesive.

### Claim 3 (depends on 2)

The method of claim 2, wherein said pores have an average diameter in a range of from about 100 microns to about 1000 microns.

### Claim 4 (depends on 2)

The method claim 2, wherein said pores are further configured to be operable for assisting in neovascularization and bone formation in said substrate bone repair region.

### Claim 5 (depends on 1)

The method of claim 1, wherein said resorbable bovine serum albumin or collagen based adhesive is broken down and assimilated back into the body by biological processes.

### Claim 6 (depends on 1)

The method of claim 1, wherein said curing step is carried out using light.

### Claim 7 (depends on 6)

The method of claim 6, wherein said curing step is carried out in a period ranging from about 10 seconds to about 60 seconds.

### Claim 8 (depends on 1)

The method of claim 1, wherein said curing step is accomplished chemically.

### Claim 9 (depends on 8)

The method of claim 8, where said curing step is carried out in a period ranging from about 20 seconds to about 120 seconds.

### Claim 10 (depends on 1)

The method of claim 1, wherein said bovine serum albumin or collagen based adhesive composition is configured to a predetermined form and cured to preserve a space volume required for bone regeneration.

### Claim 11 (depends on 1)

The method of claim 1, further comprising the steps of:
combining said bovine serum albumin or collagen based adhesive composition with a bone graft material to form an adhesive chemical composition, in which said bone graft material comprises at least one of, a synthetic material, a growth factor material, a cell material, and a combination of the cited materials;
in which said synthetic material comprises at least one of ceramics, hydroxyapatite, tricalcium phosphate, calcium phosphate, calcium sulfate, polymer based bone-graft substitutes, and composite materials;
in which said growth factors comprises at least one of a bone morphogenic protein (BMP), a BMP mimetic, a recombinant human bone morphogenic protein 2 (rhBMP-2), a platelet-rich plasma (PRP), a transforming growth factor-beta (TGF-beta), a platelet-derived growth factor (PDGF), a recombinant human platelet derived growth factor (rhPDGF), a fibroblast growth factor, a xenographic bone protein, a growth differentiation factor, a calcitonin, and a calcitonin mimetic;
in which said living cell material comprises at least one of a stem cell, a bone marrow cell, a mesenchymal stem cell, and a combination of the cited cells;
wherein said bovine serum albumin or collagen based adhesive composition in said chemical adhesive composition that is integrated with said bone graft material are configured to assist in bonding said bone graft material to said at least one of, bone structure, implant device surface, and tooth surface;
applying said combined bovine serum albumin or collagen based adhesive composition and bone graft material to said substrate bone repair region;
forming said combined bovine serum albumin or collagen based adhesive composition and bone graft material to a desired form; and
curing said adhesive chemical composition to preserve a space volume required for bone regeneration.

### Claim 12 (depends on 11)

The method of claim 11, wherein said bone graft material is at least one of a bone, a synthetic material, a growth factor, and a living cell.

### Claim 13 (depends on 12)

The method of claim 12, wherein said bone comprises at least one of, an autologous bone, an autologous bone particulate, an allogenic bone, a human cadaver bone, a xenograft bone, an animal bone, and bone chips.

### Claim 14 (depends on 12)

The method of claim 12, wherein said synthetic material comprises at least one of, a hydroxyapatite, a calcium phosphate, a ceramics, a bioactive glass, a calcium sulfate, a polymer-based bone graft substitute, and a composite material.

### Claim 15 (depends on 12)

The method of claim 12, wherein said growth factor is at least one of a bone morphogenic protein (BMP), a BMP mimetic, a recombinant human bone morphogenic protein 2 (rhBMP-2), a platelet-rich plasma (PRP), a transforming growth factor-beta (TGF-beta), a platelet-derived growth factor (PDGF), a recombinant human platelet derived growth factor (rhPDGF), a fibroblast growth factor, a xenographic bone protein, a calcitonin, and a calcitonin mimetic.

### Claim 16 (depends on 12)

The method of claim 12, wherein said living cell is at least one of, a stem cell, a bone marrow cell, and a mesenchymal stem cell.

### Claim 17 (depends on 1)

The method of claim 1, further comprising the steps of:
applying a barrier membrane over said substrate bone repair region, wherein said barrier membrane is configured to be operable for preventing soft tissues from growing into said substrate bone repair region;
applying said bovine serum albumin or collagen based adhesive composition over said barrier membrane to keep said barrier membrane in place, in said bone structure, implant device surface, or tooth surface.

### Claim 18 (depends on 11)

The method of claim 11, further comprising the step of:
applying a barrier membrane over said combined adhesive composition and bone graft material, wherein said barrier membrane is configured to prevent soft tissues from growing into said bone graft material and adhesive composition.

### Claim 19

A method comprising steps of:
combining an adhesive composition to a bone graft material, in which said adhesive composition includes at least one of, a collagen based adhesive and bovine serum albumin;
mixing said at least one of, a collagen based adhesive and bovine serum albumin adhesive composition and said bone graft material to form a chemical adhesive composition;
applying said combined at least one of, a collagen based adhesive and bovine serum albumin adhesive composition and bone graft material to a substrate bone repair region;
wherein said at least one of, a collagen based adhesive and bovine serum albumin adhesive composition comprises a porous, biocompatible, biodegradable, resorbable, or polymerizable adhesive composition; and
wherein said substrate bone repair region comprises at least one of a bone structure, an implant surface, a device surface, and a tooth surface;
curing said combined at least one of, a collagen based adhesive and bovine serum albumin adhesive composition and bone graft material;
wherein said curing step is configured to generate a polymerized at least one of, a collagen based adhesive and bovine serum albumin adhesive composition and bone graft material on the substrate bone repair region; and
wherein said ming step is configured to be operable for at least one of repairing the bone structure, filling gaps between the bone structure or implant device surface, and filling gaps in the tooth surface.

### Claim 20

A method consisting of:
applying a barrier membrane to a substrate bone repair region, said substrate bone repair region comprises at least one of, a bone structure, an implant device surface, and a tooth surface;
applying an adhesive composition to said barrier membrane, said adhesive composition includes at least a bovine serum albumin and glutaraldehyde, wherein the barrier membrane is configured to separate osseous tissue from soft tissue in said substrate bone repair region, and wherein placing the barrier membrane with the adhesive composition on the substrate bone repair region is further configured to affect a repair;
wherein the bovine serum albumin and glutaraldehyde adhesive composition comprises a porous, biocompatible, biodegradable, resorbable, or polymerizable adhesive composition;
curing the mixture to produce a polymerized adhesive composition;
wherein said curing step is configured to be operable for preventing any damage to the repair by containing any movement in the substrate bone repair region using the barrier membrane with the bovine serum albumin and glutaraldehyde adhesive composition; and
wherein said curing step is further configured to be operable for repairing the bone structure, filling gaps between the bone structure or the implant device surface, or filling gaps between the bone structure or the tooth surface.

### Claim 21

A method comprising steps of:
adding an adhesive composition to a bone graft material, in which said adhesive composition comprises at least a collagen based adhesive, and in which said bone graft material comprises at least one of, a bone material, a synthetic material, a growth factor, and a living cell;
mixing the collagen based adhesive composition and the bone graft material to form a mixture;
applying the collagen based adhesive composition and bone graft material mixture to a substrate bone repair region, in which said substrate bone repair region comprises at least one of, a bone structure, an implant device surface, and a tooth surface;
applying the collagen based adhesive composition to a barrier membrane, wherein the barrier membrane is configured to separate osseous tissue from soft tissue in said substrate bone repair region;
placing the barrier membrane with the collagen based adhesive composition over the collagen based adhesive composition and bone graft material mixture applied on the substrate bone repair region to affect a repair;
wherein the adhesive composition comprises a porous, biocompatible, biodegradable, resorbable, and polymerizable collagen based adhesive composition;
curing the collagen based adhesive composition present in the mixture and applied on the barrier membrane;
wherein said curing step is configured to produce a polymerized collagen based adhesive composition on the substrate bone repair region; and
wherein said curing step is further configured to be operable for at least one of repairing the bone structure, filling gaps between the bone structure or implant device surface, filling gaps between the bone structure or the tooth surface, and bone augmentation.
